Newtyn Management, LLC

Holdings History for Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH)

Symbol: TBPH on Nasdaq
Investment type: Equity / Ordinary Share $0.00001 par value
Latest Disclosed Shares Owned: 4,300,000 shares
Security Ownership %: 8.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Newtyn Management, LLC ownership in Theravance Biopharma, Inc. Ordinary Share $0.00001 par value (TBPH)

17 Feb 2026 - Newtyn Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,300,000 shares of Theravance Biopharma, Inc. Ordinary Share $0.00001 par value (TBPH). This represents 8.5% ownership of the company. In their previous filing dated 14 Feb 2025, Newtyn Management, LLC had reported owning 4,757,403 shares, indicating a decrease of +9.6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Newtyn Management, LLC	8.5%	-12%	$87,419,000	4,300,000	-457,403	-9.6%	$20.33	13G/A	31 Dec 2025	17 Feb 2026, 16:15
Newtyn Management, LLC	9.7%		$46,384,679	4,757,403			$9.75	13G/A	31 Dec 2024	14 Feb 2025, 16:05

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	8.5%	-1.3%	$80,453,000	4,300,000	-650,000	-13%	$18.71	Q4 2025
30 Sep 2025	8.8%	0%	$72,270,000	4,950,000	0		$14.60	Q3 2025
30 Jun 2025	8.3%	+0.32%	$54,598,500	4,950,000	+192,597	+4%	$11.03	Q2 2025
31 Mar 2025	6.8%	0%	$42,483,609	4,757,403	0		$8.93	Q1 2025
31 Dec 2024	7.8%	+0.42%	$44,767,162	4,757,403	+258,337	+5.7%	$9.41	Q4 2024
30 Sep 2024	5.6%	+2.9%	$36,262,472	4,499,066	+2,374,363	+112%	$8.06	Q3 2024
30 Jun 2024	3.4%	+0.81%	$18,017,481	2,124,703	+480,773	+29%	$8.48	Q2 2024
31 Mar 2024	2.9%	-0.46%	$14,746,052	1,643,930	-256,070	-13%	$8.97	Q1 2024
31 Dec 2023	4.2%	+0.13%	$21,356,000	1,900,000	+58,440	+3.2%	$11.24	Q4 2023
30 Sep 2023	3.9%	+0.43%	$15,892,663	1,841,560	+201,104	+12%	$8.63	Q3 2023
30 Jun 2023	4%	+0.27%	$16,978,720	1,640,456	+109,441	+7.1%	$10.35	Q2 2023
31 Mar 2023	3.3%	+0.17%	$16,611,513	1,531,015	+81,015	+5.6%	$10.85	Q1 2023
31 Dec 2022	3.4%	-2.4%	$16,269,000	1,450,000	-1,045,860	-42%	$11.22	Q4 2022
30 Sep 2022	5.6%	+1%	$25,308,000	2,495,860	+458,035	+22%	$10.14	Q3 2022
30 Jun 2022	3.5%	+1.1%	$18,463,000	2,037,825	+662,825	+48%	$9.06	Q2 2022
31 Mar 2022	3.1%	+0.86%	$13,145,000	1,375,000	+375,000	+38%	$9.56	Q1 2022
31 Dec 2021	3%	+2.7%	$11,050,000	1,000,000	+902,045	+921%	$11.05	Q4 2021
30 Sep 2021	0.19%	+0.19%	$725,000	97,955	+97,955	NEW	$7.40	Q3 2021
31 Mar 2020		-0.89%	$0	0	-173,300	-100%	$19.99	Q1 2020
31 Dec 2019	0.89%	+0.56%	$4,487,000	173,300	+109,619	+172%	$25.89	Q4 2019
30 Sep 2019	0.27%	+0.27%	$1,241,000	63,681	+63,681	NEW	$19.49	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.